Biotech

Perfeggt brings in first capital to shell out plant-based egg alternative

Worldwide, over 1.3 trillion eggs are produced annually, and Perfeggt co-founders believe this market is largely untapped and has room to grow with plant-based alternatives.

Tiamat Sciences cooking up plant-based proteins for cheaper production of cellular meat

Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.

UK-based mental health provider ieso raises $53M armed with an ‘unprecedented’ data set

U.K.-based digital therapy company ieso announced a $53 million Series B round on Tuesday. The round is the funding the company needs to move in a brand new direction: creating more intuitive autonomo

Primer Sazze Partners plans to close $127M second fund aimed at South Korean entrepreneurs in 2022

Primer Sazze Partners, a San Jose-based venture capital firm, plans to set up its second fund at $127 million (150 billion won), aiming in the first half of 2022 to invest in startups founded by Korea

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines

H1 closes $100M Series C on the back of ‘incredible traction’ and a successful first use case

Fresh off of a $58 million Series B round, and just one year after graduating from Y combinator, H1, a “LinkedIn for the healthcare industry” has raised even more cash. On Tuesday, the company ann

Trialjectory on track to match 50K cancer patients with clinical trials this year: 35% are from underrepresented groups

Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and t

Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs

In Frequency Therapeutics’ short lifetime as a company, it’s had its ups and downs. On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the d

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

Isomorphic Labs is Alphabet’s play in AI drug discovery

The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information pro

Walden Catalyst launches a $550M fund to invest in deep tech startups

Over the past 20 years, there has been a steady flight of capital away from deep tech — those science- and tech-related breakthroughs on which world-changing businesses are built, Walden Catalys

Daring Foods bites into third round in 12 months as plant-based chicken product enters Walmart

The company saw 900% growth over the past 12 months and will be using the new funding to support that growth and new innovation.

Biotech startup Shiru sprouting plant-based ingredients with new capital infusion

The company plans to have ingredients ready by next year, which means we could see the first commercial products containing Shiru’s ingredients on grocery store shelves as early as 2023.

QOA brings in seed round to do for chocolate what Oatly did for milk

Its proprietary fermentation process will enable QOA to scale production by 2035 and be able to price its "chocolate" products the same or below the cost of traditional chocolate.

Medable reaches $2.1B valuation as Tiger, Blackstone, GSR pump new capital into clinical trials management company

Medable has grown 300% in the past year and over 800% in the last 18 months, which CEO Michelle Longmire said was proof that a patient-centered approach is taking hold.

UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome

There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from anx

Modern Age is on a mission to put people in the driver’s seat of their aging journey

Modern Age provides digital tools to help users demystify and understand their aging options, including telemedicine and in-person treatments.

Overwatch Research closes $3.5 million seed round to tackle a foundational preclinical research problem

Overwatch Research, a company creating workflow software for medical research, announced a $3.5 million seed round on Tuesday. This round of funding will help Overwatch expand its presence into the U.

Quris combines AI with ‘patient on a chip’ to speed drug development and reduce animal testing

The necessity of animal testing is a sad one for the process of drug discovery, but there’s seemingly no good alternative to mice, even though they’re not particularly accurate human analo

NFX-backed Pepper Bio Emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re
Load More